Clinical Trial Update: Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin [Phase 1]

View source ↗

Summary

Phase 1 trial update on the interaction of Bexagliflozin with metformin, glimepiride and sitagliptin in type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Bexagliflozin (null)
• Glimepiride (glimepiride)
• Sitagliptin (sitagliptin)
• metformin (metformin)

Snippet

Sponsor: Theracos | Conditions: Type2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2021-07-22